Trial Profile
A Phase I Study of the Wee 1 Kinase (Wee 1) Inhibitor AZD1775 in Combination With Radiotherapy and Cisplatin in Cervical, Upper Vaginal and Uterine Cancers (10041848, 10008224, 10008238, 10046888, 10014735)
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 22 Feb 2024
Price :
$35
*
At a glance
- Drugs Adavosertib (Primary) ; Cisplatin
- Indications Adenocarcinoma; Carcinoma; Cervical cancer; Endometrial cancer; Uterine cancer; Vulvovaginal cancer
- Focus Adverse reactions
- 25 Jan 2024 Status changed from active, no longer recruiting to discontinued due to insufficient accrual rate.
- 23 Sep 2023 Planned End Date changed from 28 Nov 2023 to 21 Sep 2024.
- 09 Jun 2023 Interventional study model has been changed to single group assignment and sequential has been removed, number of treatment arms has been changed to 1 from 2.